Literature DB >> 21326716

Patient selection for surgical management of primary and metastatic liver cancers: current perspectives.

J Alexander Palesty1, Mazin Al-Kasspooles, John F Gibbs.   

Abstract

The surgical management of liver malignancies remains a mainstay in the treatment of such patients, and has benefited from dramatic advancements over the last two decades. Improvements in surgical technique, better understanding of hepatic anatomy, and improvement in anesthesiological supportive care has resulted in a decline in perioperative morbidity and operative mortality. Proper patient selection for surgical and nonsurgical treatment currently employs a multidisciplinary approach in our institution. This review will focus on the surgical treatment options for both primary and secondary liver cancers.

Entities:  

Keywords:  Liver cancer; ablative therapy; surgery

Year:  2006        PMID: 21326716      PMCID: PMC3036304          DOI: 10.1055/s-2006-939837

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  67 in total

1.  Global cancer statistics.

Authors:  D M Parkin; P Pisani; J Ferlay
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

2.  A retrospective study of the natural history of patients with liver metastases from colorectal cancer.

Authors:  C B Wood; C R Gillis; L H Blumgart
Journal:  Clin Oncol       Date:  1976-09

3.  Intraoperative ultrasound in the management of liver neoplasms.

Authors:  E D Staren; M Gambla; D J Deziel; J Velasco; T J Saclarides; K Millikan; A Doolas
Journal:  Am Surg       Date:  1997-07       Impact factor: 0.688

4.  Laparoscopic liver surgery. A report on 28 patients.

Authors:  J Marks; J Mouiel; N Katkhouda; J Gugenheim; P Fabiani
Journal:  Surg Endosc       Date:  1998-04       Impact factor: 4.584

5.  Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence.

Authors:  Giorgio Ercolani; Gian Luca Grazi; Matteo Ravaioli; Massimo Del Gaudio; Andrea Gardini; Matteo Cescon; Giovanni Varotti; Francesco Cetta; Antonino Cavallari
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

6.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

7.  Hepatic resection for metastatic colorectal cancer results in cure for some patients.

Authors:  R L Jamison; J H Donohue; D M Nagorney; C B Rosen; W S Harmsen; D M Ilstrup
Journal:  Arch Surg       Date:  1997-05

8.  Natural course of small hepatocellular carcinoma with underlying cirrhosis. A study of 30 patients.

Authors:  M Ebara; R Hatano; H Fukuda; M Yoshikawa; N Sugiura; H Saisho
Journal:  Hepatogastroenterology       Date:  1998-08

9.  Intraoperative determinants of unresectability for patients with colorectal hepatic metastases.

Authors:  J F Gibbs; T K Weber; M A Rodriguez-Bigas; D L Driscoll; N J Petrelli
Journal:  Cancer       Date:  1998-04-01       Impact factor: 6.860

10.  A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma.

Authors:  S Yamasaki; H Hasegawa; H Kinoshita; M Furukawa; S Imaoka; K Takasaki; Y Kakumoto; H Saitsu; R Yamada; Y Oosaki; S Arii; E Okamoto; M Monden; M Ryu; S Kusano; T Kanematsu; K Ikeda; M Yamamoto; T Saoshiro; T Tsuzuki
Journal:  Jpn J Cancer Res       Date:  1996-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.